|
Cancer treatment
Abstract
USC researchers have developed a technique for optimizing CAR-T and CAR-NK cell specificity that employs human leukocyte antigen DR (HLA-DR) downregulation in malignant cells. Because malignant cancer cells generally express HLA-DR at lower levels than healthy cells, CAR-NK cells inhibited against HLA-DR will preferentially...
|